Literature DB >> 25527497

PINK1 kinase catalytic activity is regulated by phosphorylation on serines 228 and 402.

Liesbeth Aerts1, Katleen Craessaerts1, Bart De Strooper2, Vanessa A Morais3.   

Abstract

Mutations in the PINK1 gene cause early-onset recessive Parkinson disease. PINK1 is a mitochondrially targeted kinase that regulates multiple aspects of mitochondrial biology, from oxidative phosphorylation to mitochondrial clearance. PINK1 itself is also phosphorylated, and this might be linked to the regulation of its multiple activities. Here we systematically analyze four previously identified phosphorylation sites in PINK1 for their role in autophosphorylation, substrate phosphorylation, and mitophagy. Our data indicate that two of these sites, Ser-228 and Ser-402, are autophosphorylated on truncated PINK1 but not on full-length PINK1, suggesting that the N terminus has an inhibitory effect on phosphorylation. We furthermore establish that phosphorylation of these PINK1 residues regulates the phosphorylation of the substrates Parkin and Ubiquitin. Especially Ser-402 phosphorylation appears to be important for PINK1 function because it is involved in Parkin recruitment and the induction of mitophagy. Finally, we identify Thr-313 as a residue that is critical for PINK1 catalytic activity, but, in contrast to previous reports, we find no evidence that this activity is regulated by phosphorylation. These data clarify the regulation of PINK1 through multisite phosphorylation.
© 2015 by The American Society for Biochemistry and Molecular Biology, Inc.

Entities:  

Keywords:  Mitochondria; Neurodegenerative Disease; PTEN-induced Putative Kinase 1 (PINK1); Parkinson Disease; Posttranslational Modification (PTM); Protein Phosphorylation; Serine/Threonine Protein Kinase

Mesh:

Substances:

Year:  2014        PMID: 25527497      PMCID: PMC4317039          DOI: 10.1074/jbc.M114.620906

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  48 in total

1.  Parkin-catalyzed ubiquitin-ester transfer is triggered by PINK1-dependent phosphorylation.

Authors:  Masahiro Iguchi; Yuki Kujuro; Kei Okatsu; Fumika Koyano; Hidetaka Kosako; Mayumi Kimura; Norihiro Suzuki; Shinichiro Uchiyama; Keiji Tanaka; Noriyuki Matsuda
Journal:  J Biol Chem       Date:  2013-06-10       Impact factor: 5.157

2.  LRRK2 controls an EndoA phosphorylation cycle in synaptic endocytosis.

Authors:  Samer Matta; Kristof Van Kolen; Raquel da Cunha; Geert van den Bogaart; Wim Mandemakers; Katarzyna Miskiewicz; Pieter-Jan De Bock; Vanessa A Morais; Sven Vilain; Dominik Haddad; Lore Delbroek; Jef Swerts; Lucía Chávez-Gutiérrez; Giovanni Esposito; Guy Daneels; Eric Karran; Matthew Holt; Kris Gevaert; Diederik W Moechars; Bart De Strooper; Patrik Verstreken
Journal:  Neuron       Date:  2012-09-20       Impact factor: 17.173

3.  Ubiquitin is phosphorylated by PINK1 to activate parkin.

Authors:  Fumika Koyano; Kei Okatsu; Hidetaka Kosako; Yasushi Tamura; Etsu Go; Mayumi Kimura; Yoko Kimura; Hikaru Tsuchiya; Hidehito Yoshihara; Takatsugu Hirokawa; Toshiya Endo; Edward A Fon; Jean-François Trempe; Yasushi Saeki; Keiji Tanaka; Noriyuki Matsuda
Journal:  Nature       Date:  2014-06-04       Impact factor: 49.962

4.  Discovery of catalytically active orthologues of the Parkinson's disease kinase PINK1: analysis of substrate specificity and impact of mutations.

Authors:  Helen I Woodroof; Joe H Pogson; Mike Begley; Lewis C Cantley; Maria Deak; David G Campbell; Daan M F van Aalten; Alexander J Whitworth; Dario R Alessi; Miratul M K Muqit
Journal:  Open Biol       Date:  2011-11       Impact factor: 6.411

5.  PINK1 controls mitochondrial localization of Parkin through direct phosphorylation.

Authors:  Yongsung Kim; Jeehye Park; Sunhong Kim; Saera Song; Seok-Kyu Kwon; Sang-Hee Lee; Tohru Kitada; Jin-Man Kim; Jongkyeong Chung
Journal:  Biochem Biophys Res Commun       Date:  2008-10-26       Impact factor: 3.575

6.  Loss-of-function of human PINK1 results in mitochondrial pathology and can be rescued by parkin.

Authors:  Nicole Exner; Bettina Treske; Dominik Paquet; Kira Holmström; Carola Schiesling; Suzana Gispert; Iria Carballo-Carbajal; Daniela Berg; Hans-Hermann Hoepken; Thomas Gasser; Rejko Krüger; Konstanze F Winklhofer; Frank Vogel; Andreas S Reichert; Georg Auburger; Philipp J Kahle; Bettina Schmid; Christian Haass
Journal:  J Neurosci       Date:  2007-11-07       Impact factor: 6.167

7.  A dimeric PINK1-containing complex on depolarized mitochondria stimulates Parkin recruitment.

Authors:  Kei Okatsu; Midori Uno; Fumika Koyano; Etsu Go; Mayumi Kimura; Toshihiko Oka; Keiji Tanaka; Noriyuki Matsuda
Journal:  J Biol Chem       Date:  2013-11-04       Impact factor: 5.157

Review 8.  Genetic etiology of Parkinson disease associated with mutations in the SNCA, PARK2, PINK1, PARK7, and LRRK2 genes: a mutation update.

Authors:  Karen Nuytemans; Jessie Theuns; Marc Cruts; Christine Van Broeckhoven
Journal:  Hum Mutat       Date:  2010-07       Impact factor: 4.878

9.  The PINK1/Parkin pathway regulates mitochondrial morphology.

Authors:  Angela C Poole; Ruth E Thomas; Laurie A Andrews; Heidi M McBride; Alexander J Whitworth; Leo J Pallanck
Journal:  Proc Natl Acad Sci U S A       Date:  2008-01-29       Impact factor: 11.205

10.  Parkinson's disease mutations in PINK1 result in decreased Complex I activity and deficient synaptic function.

Authors:  Vanessa A Morais; Patrik Verstreken; Anne Roethig; Joél Smet; An Snellinx; Mieke Vanbrabant; Dominik Haddad; Christian Frezza; Wim Mandemakers; Daniela Vogt-Weisenhorn; Rudy Van Coster; Wolfgang Wurst; Luca Scorrano; Bart De Strooper
Journal:  EMBO Mol Med       Date:  2009-05       Impact factor: 12.137

View more
  40 in total

1.  Calcium/calmodulin-dependent protein kinase regulates the PINK1/Parkin and DJ-1 pathways of mitophagy during sepsis.

Authors:  Xianghong Zhang; Du Yuan; Qian Sun; Li Xu; Emma Lee; Anthony J Lewis; Brian S Zuckerbraun; Matthew R Rosengart
Journal:  FASEB J       Date:  2017-06-14       Impact factor: 5.191

Review 2.  Mitochondrial network remodeling: an important feature of myogenesis and skeletal muscle regeneration.

Authors:  Fasih Ahmad Rahman; Joe Quadrilatero
Journal:  Cell Mol Life Sci       Date:  2021-03-22       Impact factor: 9.261

Review 3.  Mechanisms of PINK1, ubiquitin and Parkin interactions in mitochondrial quality control and beyond.

Authors:  Andrew N Bayne; Jean-François Trempe
Journal:  Cell Mol Life Sci       Date:  2019-06-28       Impact factor: 9.261

Review 4.  Targeting Mitochondria as a Therapeutic Approach for Parkinson's Disease.

Authors:  Maryam Abrishamdar; Maryam Sadat Jalali; Yaghoob Farbood
Journal:  Cell Mol Neurobiol       Date:  2022-08-11       Impact factor: 4.231

Review 5.  Targeting Pink1-Parkin-mediated mitophagy for treating liver injury.

Authors:  Jessica A Williams; Wen-Xing Ding
Journal:  Pharmacol Res       Date:  2015-10-24       Impact factor: 7.658

Review 6.  The ubiquitin signal and autophagy: an orchestrated dance leading to mitochondrial degradation.

Authors:  Koji Yamano; Noriyuki Matsuda; Keiji Tanaka
Journal:  EMBO Rep       Date:  2016-02-08       Impact factor: 8.807

7.  PINK1 autophosphorylation is required for ubiquitin recognition.

Authors:  Shafqat Rasool; Naoto Soya; Luc Truong; Nathalie Croteau; Gergely L Lukacs; Jean-François Trempe
Journal:  EMBO Rep       Date:  2018-02-23       Impact factor: 8.807

Review 8.  Cargo recognition and degradation by selective autophagy.

Authors:  Damián Gatica; Vikramjit Lahiri; Daniel J Klionsky
Journal:  Nat Cell Biol       Date:  2018-02-23       Impact factor: 28.824

9.  Structure of PINK1 in complex with its substrate ubiquitin.

Authors:  Alexander F Schubert; Christina Gladkova; Els Pardon; Jane L Wagstaff; Stefan M V Freund; Jan Steyaert; Sarah L Maslen; David Komander
Journal:  Nature       Date:  2017-10-30       Impact factor: 49.962

Review 10.  Mediators of mitophagy that regulate mitochondrial quality control play crucial role in diverse pathophysiology.

Authors:  Rudranil De; Somnath Mazumder; Uday Bandyopadhyay
Journal:  Cell Biol Toxicol       Date:  2020-10-17       Impact factor: 6.691

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.